FDA data Registry peer set 2 peers

Alternatives to rivastigmine

2 same-class SPL records vs rivastigmine - uses, FAERS reaction fields, and OTC/Rx flags from public FDA sources.

Brand: Exelon

Acetylcholinesterase Inhibitor Prescription 2 alternatives found

About rivastigmine

Rivastigmine (Exelon) is a medicine that helps improve memory and thinking in people with dementia. It works by increasing a chemical in the brain that is important for these functions.

Used for: This medicine treats mild to moderate dementia caused by Alzheimer's disease. It also treats mild to moderate dementia linked to Parkinson's disease. Dementia affects memory, thinking, and the ability to do daily activities.

2 Acetylcholinesterase Inhibitor peers (wide set)

Compare rivastigmine vs donepezil side-by-side →

rivastigmine vs donepezil & galantamine · FAERS reaction fields

FAERS top-reaction field "Fall" shows the widest count spread between rivastigmine and donepezil, galantamine in this extract (1,301-report gap on that field). Counts are exposure-weighted submissions, not prevalence rates.

Side Effect rivastigmine donepezilgalantamine
Death 2,177 2,020 -
Fall 1,664 2,965 375
Hallucination 1,365 1,481 77
Confusional State 1,258 1,893 75
Vomiting 885 1,276 -
Nausea 827 1,599 -
Dizziness 771 1,732 -
Gait Disturbance 713 - -

"-" means no reports for that reaction. Report counts reflect total FAERS submissions, not prevalence rates.

rivastigmine peer mix vs class inventory

Peer mix

0 OTC and 2 Rx SPL records in this peer set (2 total). Class inventory for Acetylcholinesterase Inhibitor: 3 drugs.

Frequently Asked Questions

What same-class SPL records sit beside rivastigmine?
This registry lists 2 Acetylcholinesterase Inhibitor medication records beside rivastigmine, including donepezil, galantamine. Grouping is therapeutic-class indexing from openFDA/SPL, not a product recommendation.

Reading a wide Acetylcholinesterase Inhibitor peer set (2 records)

rivastigmine (Exelon) sits in a wide Acetylcholinesterase Inhibitor peer set (2 of 2 class peers shown). Labeled indication field for rivastigmine: This medicine treats mild to moderate dementia caused by Alzheimer's disease.

Top FAERS reaction fields for rivastigmine total 10,998 reports across 10 reactions, set beside donepezil, galantamine. Counts are exposure-weighted submissions, not per-patient risk.

Registry note: Therapeutic-class peer lists are registry indexes, not prescribing advice. This information is for educational purposes only and is not a substitute for professional medical advice. Do not stop or change your medication without talking to your doctor or pharmacist.

Full rivastigmine profile →

Field note for rivastigmine: see also the generic vs brand label guide when reading Exelon SPL strings.